News
A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes ...
A US judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and ...
April 24 - A U.S. judge on Thursday rejected a bid by compounding pharmacies to keep making copies of Novo Nordisk's popular diabetes and weight-loss drugs Ozempic and Wegovy while a legal challenge ...
Harvard Medical School experts reported that a rapid loss of fat in the face can cause a hollowed look to the face; changes ...
But, like all medications, there are side effects to using both Ozempic and Mounjaro with several celebrities sharing their ...
Viking's Q1 earnings show no revenue, increased R&D spending, and a substantial cash reserve, positioning it well for future ...
SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...
A woman who privately purchased an injectable GLP-1 weight-loss medication is claiming it made her hair fall out and gave her ...
A DAD once nicknamed “Fat Pal” by his friends has dropped five stone in five months after using Mounjaro. Sean Burns, 32, from Glasgow, said he has “struggled with excess weight” his whole life ...
Compared with other antidiabetic medications, semaglutide was linked to a significantly lower risk of opioid overdose in ...
An estimated 24,499 people visited the ED for adverse events related to semaglutide in the 2 years after its approval for ...
6h
News-Medical.Net on MSNWhat’s behind Gen Z’s skepticism about Ozempic and WegovyA U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results